Virginia Commonwealth University

VCU Scholars Compass
Family Medicine and Population Health
Publications

Dept. of Family Medicine and Population Health

2015

Supporting Practices to Adopt Registry-Based Care
(SPARC): protocol for a randomized controlled
trial
Rebecca S. Etz
Virginia Commonwealth University, rsetz@vcu.edu

Rosalind E. Keith
Mathematica Policy Research

Anna M. Maternick
Virginia Commonwealth University, maternickam@vcu.edu
See next page for additional authors

Follow this and additional works at: http://scholarscompass.vcu.edu/fmph_pubs
Part of the Medicine and Health Sciences Commons
Copyright © Etz et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons
Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made
available in this article, unless otherwise stated.

Downloaded from
http://scholarscompass.vcu.edu/fmph_pubs/22

This Article is brought to you for free and open access by the Dept. of Family Medicine and Population Health at VCU Scholars Compass. It has been
accepted for inclusion in Family Medicine and Population Health Publications by an authorized administrator of VCU Scholars Compass. For more
information, please contact libcompass@vcu.edu.

Authors

Rebecca S. Etz, Rosalind E. Keith, Anna M. Maternick, Karen L. Stein, Roy T. Sabo, Melissa S. Hayes, Purvi
Sevak, John Holland, and Jesse C. Crosson

This article is available at VCU Scholars Compass: http://scholarscompass.vcu.edu/fmph_pubs/22

Etz et al. Implementation Science (2015) 10:46
DOI 10.1186/s13012-015-0232-2
Implementation
Science

STUDY PROTOCOL

Open Access

Supporting Practices to Adopt Registry-Based Care
(SPARC): protocol for a randomized controlled trial
Rebecca S Etz1*, Rosalind E Keith2, Anna M Maternick1, Karen L Stein1, Roy T Sabo1, Melissa S Hayes1, Purvi Sevak2,
John Holland2 and Jesse C Crosson2

Abstract
Background: Diabetes is predicted to increase in incidence by 42% from 1995 to 2025. Although most adults with
diabetes seek care from primary care practices, adherence to treatment guidelines in these settings is not optimal.
Many practices lack the infrastructure to monitor patient adherence to recommended treatment and are slow to
implement changes critical for effective management of patients with chronic conditions. Supporting Practices to
Adopt Registry-Based Care (SPARC) will evaluate effectiveness and sustainability of a low-cost intervention designed
to support work process change in primary care practices and enhance focus on population-based care through
implementation of a diabetes registry.
Methods: SPARC is a two-armed randomized controlled trial (RCT) of 30 primary care practices in the Virginia
Ambulatory Care Outcomes Research Network (ACORN). Participating practices (including control groups) will be
introduced to population health concepts and tools for work process redesign and registry adoption at a meeting
of practice-level implementation champions. Practices randomized to the intervention will be assigned study peer
mentors, receive a list of specific milestones, and have access to a physician informaticist. Peer mentors are clinicians
who successfully implemented registries in their practices and will help champions in the intervention practices
throughout the implementation process. During the first year, peer mentors will contact intervention practices monthly
and visit them quarterly. Control group practices will not receive support or guidance for registry implementation. We will
use a mixed-methods explanatory sequential design to guide collection of medical record, participant observation, and
semistructured interview data in control and intervention practices at baseline, 12 months, and 24 months. We will use
grounded theory and a template-guided approach using the Consolidated Framework for Implementation Research
to analyze qualitative data on contextual factors related to registry adoption. We will assess intervention effectiveness
by comparing changes in patient-level hemoglobin A1c scores from baseline to year 1 between intervention and
control practices.
Discussion: Findings will enhance our understanding of how to leverage existing practice resources to improve
diabetes care in primary care practices by implementing and using a registry. SPARC has the potential to validate
the effectiveness of low-cost implementation strategies that target practice change in primary care.
Trial registration: NCT02318108
Keywords: Population health, Diabetes, Disease registry, Implementation, Primary care, Sustainability

* Correspondence: rsetz@vcu.edu
1
Department of Family Medicine and Population Health, Virginia Commonwealth
University, 830 East Main Street, Room 629, PO Box 980101, Richmond, VA
23298-0101, USA
Full list of author information is available at the end of the article
© 2015 Etz et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.

Etz et al. Implementation Science (2015) 10:46

Background
Diabetes is the seventh leading cause of death in the
United States and currently affects more than 25 million
US adults, resulting in total related health costs of more
than $170 billion annually [1-7]. Many diabetic complications could be prevented with improved management
of glycemia, blood pressure, and lipids. However, this
management remains suboptimal in many primary care
settings where diabetes care suffers from ‘clinical inertia’
or the failure to appropriately intensify treatment by
adding new treatments to achieve control of glycemia,
hypertension, and dyslipidemia [8-17]. Because most patients with diabetes and other chronic conditions seek
care from primary care practices, improving care in
these settings will have a large impact on reducing
diabetes-related excess morbidity and mortality and may
also help control the costs of diabetes [18]. However,
primary practices often lack an effective infrastructure
for systematically monitoring their patients’ achievement
of diabetes treatment goals to ensure that they are adhering to clinical guidelines [19].
The Chronic Care Model (CCM) is a population-based
approach to care delivery that, after it is adopted, can
enhance the abilities of primary care practices to improve adherence to clinical guidelines and outcomes by
standardizing care delivery [20,21]. This process involves
the implementation of registries, which allow practices
to better track and monitor the care needs of their patients, providing the opportunity to identify and address
clinical inertia among patients with diabetes [22]. The
CCM supports the coordinated care that is a key aspect
of the patient-centered medical home (PCMH) [23]
model, the implementation of which has been shown to
improve outcomes for patients with diabetes [24-26].
Unfortunately, a recent study of PCMH implementation
in Virginia found that only 1% of practices were able
to fully meet all PCMH requirements [27-29]. Most
Virginia-based practices had introduced some elements
of the PCMH model into their practice but had not focused on using the electronic health record (EHR) effectively for population-based care. For example, the
study reported that only 33% of primary care practices
in Virginia actively use their EHR for population management tasks such as those supported by registry usage
[27-29]. This demonstrates that even those practices that
have been able to achieve PCMH transformation have
difficulty making population-based care a meaningful
part of their everyday practice.
Transformational change that the implementation of
CCM and PCMH requires often is overwhelming for
primary care practices that are burdened by a payment
system that has not consistently supported care management work. With recent changes to the US Medicare
payment system (and to some systems of private payers
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as well), primary care practices will now have the opportunity to be compensated for chronic care management
services [30,31]. Even with these changes to the payment
system, however, many primary care practices do not
have structures in place to easily make changes to care
delivery or work processes to support monitoring of
patients with chronic illness. For these PCMH and care
management innovations to benefit patients with diabetes, these practices likely will struggle to adopt and
implement new workflows that focus on addressing patient care needs and clinical inertia [24,27,32,33].
SPARC: a low-cost intervention to facilitate populationbased care

The Supporting Practices to Adopt Registry-Based Care
(SPARC) intervention aims to help primary care practices in Virginia develop a population-based care delivery approach to improve care and outcomes for their
patients with diabetes. SPARC provides basic support
to practices to enable them to implement workflow
changes to develop a diabetes registry and use it to manage and improve the care their patients receive. We define a diabetes registry as a searchable list of all patients
in a practice who have type 2 diabetes that can be used
to monitor patient records and identify gaps in care, lack
of adherence to clinical guidelines, or potential instances
of clinical inertia, to support patient outreach between
scheduled office visits. Diabetes registries typically include clinical and administrative information. Clinical
information commonly includes hemoglobin A1c levels,
blood pressure, lipid levels, and preventive health screening
information for all patients with diabetes. Administrative
information varies more widely, but it often includes the
date of each patient’s last visit and available demographic
information, such as contact information, race and ethnicity, gender, and family supports. The SPARC intervention
will focus on supporting practices’ development and use of
diabetes registries for proactive care management to help
patients achieve better diabetes control and prevent avoidable complications.
SPARC supports practices by advising them on registry
development and helping them use existing resources to
make workflow changes for successful registry implementation and use. Previous studies have focused on ensuring registry adoption through reliance on outside
change agents, such as expert facilitators and evaluators
[34-36]. However, interventions that rely exclusively on
external resources require consistent funding support
for these resources after the project ends. Helping
practices use their own internal resources encourages
sustainable practice-level innovation that can support
problem-solving beyond the initial focus of this study on
registry implementation and use. This approach also allows practice members to have complete control over
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their decisions, as well as flexibility to adapt the registry
intervention so it will work best for their practice.
Through the careful use of limited support resources,
SPARC is designed to be low cost and to yield contextspecific solutions, thereby increasing its replicability in a
variety of settings. SPARC has the potential to affect the
design of future interventions by validating the effectiveness of such low-resource implementation strategies that
target practice change in primary care.
Foundational research

Critical elements of the SPARC intervention were first
identified through two previous studies. The Translating
Research Into Action for Diabetes study found that improvements in processes of diabetes care (such as ensuring routine, periodic measurement of A1c) were not
necessarily associated with improvements in intermediate clinical outcomes (such as A1c levels). Therefore,
practice-level efforts to improve care for patients with
diabetes will need to move beyond ensuring adequate
monitoring alone to a more proactive focus on improving the management of care and appropriate treatment
intensification for these patients—that is, a focus on acting on those measurements, when appropriate [37-39].
In addition, we pilot tested the feasibility of a low-cost
approach to facilitate diabetes registry implementation
and use through the Organizational Self-Assessment
to Improve Diabetes Care in Primary Care Practices
(R34DK075417) study, referred to hereafter as the R34
pilot study or the R34 study. In that study, six primary
care practices worked to implement and use a diabetes
registry. Four practices successfully implemented a diabetes registry and increased the percentage of their
patients with HbA1c ≤ 7.0 from 77.4 to 79 (p = 0.001),
with nonsignificant improvements in the percentage of
patients with appropriate control of LDL and blood
pressure.
Since the completion of the prior pilot study, there
have been advances in EHR capabilities, and their use
has continued to increase among primary care practices.
For example, EHRs certified by the Office of the
National Coordinator for Health Information Technology as meeting the standards for the Meaningful Use
program sponsored by the Centers for Medicare and
Medicaid Services must have registry functionality available as either a built-in function or an add-on module
[40]. Therefore, practices participating in SPARC may be
able to use EHR-based registry functions not available at
the time of the previous pilot study. If participating
SPARC practices have an EHR with registry functionality, the SPARC research team will encourage them to
use that function. Otherwise, the research team will offer
information on how to use a free manual registry software program.
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Study aims

The SPARC study will test a diabetes registry implementation intervention that provides low-intensity technical
assistance and peer mentor support to primary care
practice-level leaders as they focus on improving the
quality of diabetes care in their practices. We will evaluate the effectiveness and cost-effectiveness of SPARC
using the methods described below.
The SPARC study has the following aims:
Aim 1: Conduct a randomized clinical trial to evaluate
the effectiveness of a multifaceted work process
redesign intervention for the implementation and use
of a diabetes care registry in primary care practice.
Aim 2: Evaluate the effect of the intervention on
diabetes processes of care and patient outcomes.
Aim 3: Evaluate the costs and cost-effectiveness
of the intervention in primary care practices.
Aim 4: Conduct a qualitative evaluation of the
intervention implementation to fully understand the
factors associated with success.

Methods
SPARC is a two-armed RCT comparing the intervention
condition of low-intensity technical assistance and peer
mentor support for implementing a diabetes registry
with the control condition of basic education on population health. We will evaluate the clinical effectiveness
and cost-effectiveness of a low-cost intervention for
implementing diabetes registries in primary care practices. This study was reviewed by the Virginia Commonwealth University (VCU) Institutional Review Board
(IRB) and deemed exempt, because it presents minimal
risk to participants and will not be collecting identifiable
data on human subjects. SPARC is funded by the National Institute for Diabetes and Digestive and Kidney
Diseases and is conducted jointly by researchers in the
Department of Family Medicine and Population Health
of VCU and Mathematica Policy Research. The New
England IRB has reviewed and approved this study.
Setting and recruitment

The intervention will target 30 Virginia internal medicine and family medicine practices participating in the
Virginia Ambulatory Care Outcomes Research Network
(ACORN) [41]. ACORN, sponsored by VCU, is a practicebased research network of nearly 100 primary care practices. Member practices are in rural, urban, and suburban
settings and range from single-clinician practices to large
practice groups and hospital-owned clinics. ACORN member practices choose which studies to be involved in and receive no specific benefit as part of their membership, other
than the opportunity to contribute to advancing the science
of primary care.

Etz et al. Implementation Science (2015) 10:46

Practices eligible to participate in SPARC must meet
the following criteria: (1) the practice must treat adult
patients with type 2 diabetes, (2) the clinicians and staff
in the practice must be able to change workflows in support of the intervention, and (3) the practice must have
a clinician champion who can attend champion meetings
(described below) and lead registry implementation in
the practice. Practices already using a registry or those
that do not currently use an EHR are excluded from
participation.
Randomization

To ensure a balance between the intervention and control groups of practices on the key practice characteristics of setting (rural or urban), size (fewer than three,
versus three or more, clinicians), and ownership type
(independent or group), the 30 practices were divided
into the eight strata formed by these three characteristics and then randomized with equal probability between
intervention and control using a random number generator, with 15 practices allocated to the intervention
group and 15 to the control group. Each practice was
assigned a study identification number upon allocation.
Once a year, participating practices will provide the
SPARC research team with the total number of adult patients with type 2 diabetes in their practice. Using that
number as an upper threshold, a biostatistician on the
SPARC research team will generate 100 random numbers for each practice. This number list will be used to
identify 100 patient medical records for review in each
practice.
Sample size and power analysis

For evaluating intervention effectiveness, we will review
100 patient records in each of the 30 practices at baseline and 1- and 2-year follow-up intervals. We will draw
independent random samples of patient records for each
of these reviews, and data will be recorded without patient identifiers. Because patients are not recruited and
are not the subjects of the intervention, patient dropout
is not a significant issue.
The primary outcome variable is patients’ hemoglobin
A1c levels. The research team obtained data on patient
hemoglobin A1c levels from practices that participated
in the R34 pilot, finding a mean of 7.1, a standard deviation of 1.6, and an intraclass correlation coefficient of
0.065, providing 80% power to detect a 0.5-level decrease in mean hemoglobin A1c from baseline to 1 year
in the intervention arm as opposed to the control arm,
allowing for up to 20% or six of the participating practices to drop out. If fewer practices drop out of the
study, we will have 80% power to detect 15% improvement in the percentage of patients with LDL < 100 (from
53% at baseline to 61% at follow-up), a 20% increase in
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the percentage of patients with BP < 130/80 (42.2% baseline, 50.6% follow-up), and a 25% increase in the percentage of patients in each practice with HbA1c < 7
(59.2% to 74%). The anticipated baseline rates for these
outcomes are derived from baseline rates observed in
the pilot study practices.
Participants

Each participating practice will identify two champions.
One will be a clinician; the other could be anyone in the
practice, including nonclinical staff, who could work
regularly with a registry should one be implemented.
Clinician champions must meet the following criteria:
the clinician must be a medical doctor, doctor of osteopathy, physician assistant, or nurse practitioner; have their
principal employment in the practice; be authorized to
lead a practice improvement process; and regularly provide care to patients with type 2 diabetes.
Intervention activities

Intervention and control practices will differ in the level
of support and type of resources offered by the research
team. All practices will participate in champion meetings
at least twice during the project period. All practices will
receive basic technical assistance if they are unable to
identify their total patient population with type 2 diabetes. In addition to these activities, however, intervention practices will be paired with peer mentors and will
be given access to continuing basic technical assistance
offered by a physician informaticist with expertise in
primary care data systems and reporting. Following the
recommended criteria for specifying and reporting
implementation strategies put forth by Proctor and colleagues, we specify the operationalization of our SPARC
implementation strategy in Table 1 [42]. Next, we provide details of these project elements.
Champion meetings

Two champion meetings will be held for all participating
practices. Control practices and intervention practices
will meet separately. The first champion meeting will be
largely the same for control and intervention practices.
These meetings will provide an opportunity for participants
to learn about diabetes registries, workflow redesign, and
general principles regarding population-based approaches
to care delivery for patients with chronic conditions. Participants will be introduced to a practice self-assessment
checklist tool, designed during the R34 pilot project, to help
practices plan workflow changes and registry goals. They
will gain insights into what they need to discuss with their
EHR vendor to make the registry work and will learn about
software options available if their current EHR does not
support a registry function. Champions will be introduced
to the SPARC research team and will provide basic baseline
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Table 1 Specification of the SPARC intervention strategy
Specification domain

Specification of intervention strategy

Actors

Peer mentors: clinicians who have implemented and maintained a diabetes registry in their practice
Physician informaticists: clinicians with expertise in primary care data systems and reporting

Actions

1) Two champion meetings
• Provide education to intervention and control practices on how to implement a diabetes registry, including:
− Registry development
− Population health in primary care delivery
− The American Diabetes Association’s guidelines for patients with diabetes
− Diabetes registry software options or communicating with EHR vendors about registry functionality
− A practice self-assessment checklist designed to help practices plan and manage potential workflow changes
• Facilitate discussion among intervention practices about the challenges faced during registry implementation and
solutions developed to overcome those challenges
• Provide intellectual space for intervention practices to process what they are learning and talk about their experiences
with registry implementation, as well as develop a plan for sustaining or expanding their registry
2) Peer mentoring
• Advise intervention practices on registry implementation and using the materials disseminated at champion meetings.
• Provide intervention practices with access to physician informaticists to assist with use of practice data systems.

Target of the actions

Temporality and dose

Practice champions: two champions from each intervention and control practice—one clinician champion and one
champion who will be a potential user of a registry—will attend the champion meetings. Champions in intervention
practices will work with the peer mentor.
1) Champion meetings
• One champion meeting will be held before the intervention period and a second about 15 months later.
2) Peer mentoring
• Peer mentors will work with practice champions in intervention practices for the first 12 months of the intervention,
maintaining monthly communication through telephone calls and practice visits.

Implementation outcome(s) Change in mean patient hemoglobin A1c scores
effected
Justification

We believe that helping practices use existing resources and learn how to solve problems to implement a diabetes
registry and related workflow changes will be more sustainable than implementation strategies that rely more heavily
on external resources.

demographic information on their practices and mix of patients. They will leave the meeting with a packet of information that includes the American Diabetes Association’s
guidelines for patients with diabetes.
In addition to the champion meeting elements, intervention practices will receive two pieces of information
not shared with control practices. First, they will be
introduced to their peer mentors and will receive a
document outlining basic implementation milestones
(described below and in Additional file 1). Second, they
will be introduced to a physician informaticist who will
be available to them by telephone to answer basic questions during the study.
At the second champion meeting, 15 months later,
participants will discuss the challenges they faced during
registry implementation and solutions they developed to
meet those challenges. This meeting will provide intellectual space for practices to process what they have
learned and how they have changed during registry implementation. The research team will share preliminary

findings from the first year with study participants.
These will include patterns identified in the qualitative
data by research analysts and changes in chart audit data
from baseline to year 1. Practice members will be invited
to help explain the significance of those findings. They
will also be led in a discussion regarding plans to sustain,
and for some expand, their now-existing registry.
Peer mentors and physician informaticists

Peer mentors, available only to the intervention practices, are practicing clinicians who have successfully implemented and maintained a diabetes registry in their
practice. The peer mentors will attend the first champion meeting for intervention practices to present information on registry development and answer questions
about it. After the meeting, clinician champions from
intervention practices will be paired with a peer mentor
who will advise them on the use of the self-assessment
tool and will offer basic guidance regarding workflow redesign. Peer mentors will visit each intervention practice
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at least twice during the first study year: once at baseline
and once shortly after the practice begins using the
registry. In between these visits, peer mentors will call
practice-level champions in the intervention practices
monthly to monitor implementation progress, offer assistance, and help the practice connect to basic technical
assistance from the physician informaticist if needed.
Practice-level champions can contact the peer mentors
by telephone or email throughout the intervention
period.
Some practices will be able to adopt registries successfully with little additional support; others may need
some limited technical assistance or guidance. Peer mentors will tailor their efforts to specific practice situations
to meet these varied needs. The mentors’ decisions regarding the need for additional in-person visits or more
frequent telephone contact will be guided by the SPARC
Milestones document, which outlines eight critical steps
in the meaningful adoption of a diabetes registry (see
Additional file 1). This document will also be shared
with intervention practices during the first champion
meeting. Peer mentors will use this document to assess
monthly implementation progress for each intervention
practice and determine whether a specific practice needs
additional support.
Peer mentors will identify practices that would benefit
from assistance from a physician informaticist as they
implement their registry. The physician informaticists
are primary care physicians with experience and expertise in primary care data systems and reporting who will
be available to help practice champions with such tasks
as querying existing records to populate stand-alone
registry systems, identifying changes to work processes
to ensure structured data entry of specific fields needed
to populated integrated registry systems, and developing
reports based on registry data.
An activity log of peer mentor and physician informaticist contacts and provision of basic technical assistance
will be maintained to assess the level of effort provided
to participating practices. These work logs will inform
the cost and cost-effectiveness evaluation of the intervention, as described below.
Data collection

SPARC researchers will collect data using mixed-methods
explanatory sequential design [43]. In such a design, data
collection happens in iterative cycles during which preliminary findings from one set of data influence data points
collected in the next set of data. For example, findings during a chart audit review might identify the need for collection of qualitative data elements not previously identified,
so that the significance of chart audit findings might be better understood. Data collected in SPARC will include medical record review, cost data, participant observations, key
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informant interviews, and in-depth interviews with practice
champions and project leads [44]. Data collection will occur
at baseline, 12 months post-registry implementation, and
24 months post-registry implementation. We understand it
is possible that not all practices will successfully implement
a diabetes registry and that some control practices may implement a registry without assistance. Based on our findings
from the R34 pilot study, initial adoption of a registry will
take up to 3 months. We will use medical record reviews
(described in the next section) to collect patient outcome
data (mainly hemoglobin A1c) with which we will evaluate
the effectiveness of the registry. Data collected during qualitative site visits (described below) will allow SPARC researchers to evaluate the contextual factors and practice
characteristics associated with successful implementation of
a diabetes registry, including any barriers or problemsolving strategies that practices employ to enable registry
implementation. During qualitative site visits, we will also
collect information related to cost of the intervention in
each practice.
Medical record reviews

We will review the medical records of 100 randomly selected patients with diabetes from each participating
practice to assess diabetes care quality at baseline,
12 months, and 24 months. These records will be selected from lists generated by practices at the start of
the study period, as well as at each subsequent review
point, of all patients with a visit coded with an ICD diagnosis code for type 2 diabetes, excluding any patients
who are pregnant, under age 18, or over age 75. A
trained medical record reviewer will visit practices to
conduct reviews; reviews will be done with a structured
abstraction or audit instrument. To provide quality
assurance, a different staff member will review 10% of
the already reviewed records. Medical record reviews
will be standardized across all practices. In addition,
each review may include up to five questions added at
the participating practice’s request. During practice recruitment, practices were able to review the standardized
chart review instrument and suggest additions most
beneficial to their setting. If practices requested additional
items, those items are added to the review of their practice
information only. Data from medical record reviews will be
directly entered into the study database using an electronic
tablet-based instrument designed in SharePoint. In addition
to data specified by the audit form, medical record reviewers will take notes regarding where in the record information was found and at what level of standardization
within the practice.
Qualitative site visits

SPARC researchers will visit each participating intervention
and control practice to assess practice organizational
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characteristics and workflow related to care of patients with
diabetes. Site visits will be conducted at three points during
the study: at baseline, 12 months, and 24 months.
Researchers will use four primary methods for data
collection during the site visits: participant observation,
key informant interviews, cost survey instruments, and
semistructured clinician interviews. Participant observations will consist of three to four observation periods in
each practice, each period lasting 3 to 5 h. Observations
will be guided by an observational template developed
during the R34 pilot study and refined for use in this
project. SPARC researchers will observe practice workflow, care delivery, and check-in processes, with special
attention paid to diabetes-specific and registry-specific
activities. During observations, researchers will identify
two or three practice members for interviews to learn
more about workflow changes in registry implementation. Qualitative site visits will also include interviews
with practice managers or administrators to collect cost
data relevant to registry implementation.
Measuring registry cost

To estimate cost-effectiveness of the registry, we will
compare costs experienced by intervention and control
practices. At the 12- and 24-month site visits, SPARC
researchers will collect practice-level ongoing operational costs in treating patients with diabetes. The instrument records the amount of time that clinicians,
nurses, and office staff spend on patient encounters,
chart reviews, and reports.
In addition to operational costs, the registry may entail
start-up costs to practices. We will measure start-up
costs, including purchases, staff training time, identification of patients for inclusion in a registry, and data entry
during the baseline site visits. We will measure costs associated with use of peer mentors and physician informaticists by reviewing their activity logs.
We will estimate the dollar value of time spent by office staff and peer mentors using average wage rates by
occupation, in Virginia, from the US Bureau of Labor
Statistics.
Outcomes
Statistical analysis

We will assess intervention effectiveness by comparing
the change in patient-level hemoglobin A1c scores from
baseline to year 1 between intervention and control
practices. A linear mixed-effects model will be used to
account for the continuous repeated-measure response
(A1c), a fixed-effect group indicator (two levels: intervention, control), a fixed-effect time indicator (two
levels: baseline, year 1), and an interaction of the group
and time indicators. A practice-level random effect will
be included to account for intracluster correlation. Any
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adjustments to this model for patient- or practice-level
characteristics will be made by including those measures
as fixed effects. We will analyze secondary effectiveness
measures using similar linear mixed-effects models of
numerical and categorical measurements, including
whether diabetes patients met targets for blood pressure
control or LDL cholesterol.
We will assess intervention maintenance of the change
in A1c scores using a similar model, with the time
periods changing to baseline and year 1, and year 1 to
year 2. We will assess practice-level implementation and
maintenance using t-tests for unadjusted comparisons
and using analysis of covariance to adjust differences for
practice characteristics. We will categorize practices
according to their allocated group, regardless of compliance (intention-to-treat analysis) [45].
Cost analysis

We will calculate cost-effectiveness ratios by dividing the
difference in intervention costs between the control and
intervention groups by the difference in outcomes (for
example, HbA1c) between the control and intervention
groups. Results can be used to share cost-related
information, such as the cost to a practice (or potential
sponsor) for a .5 percentage point reduction in the mean
A1c level across their patients with diabetes, with other
practices. Because overall health care expenditures are
lower for patients with good HbA1c control than for
those with poor control, these practice-level intervention
costs will also be compared to expected reductions in
overall health care expenditures to estimate the potential
societal impact of the intervention on health care expenditures [46].
Qualitative analysis

Analysis of qualitative site visit data will be conducted
using grounded theory and a template-based analysis
using the Consolidated Framework for Implementation
Research [47]. SPARC researchers will identify practice
characteristics (such as organizational structure), the
practice’s ability to successfully implement a registry,
and changes from registry implementation or consequences ascribed to it. SPARC researchers will create a
codebook based on themes discovered in a preliminary
reading of the data. The SPARC team will then code all
available qualitative data from observations and interviews using ATLAS.ti. The team will use a consensus
approach to create reliable and validated use of the
codebook and will conduct quality assurance audits on
10% of all coded data. As a result of this process, some
codes may be dropped and new codes added. After coding is complete, team members will begin the analysis
process by highlighting major themes and relationships
discovered throughout the coded data. The primary
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goals for this analysis are to (1) examine practices’ diverse responses to the intervention and (2) learn how
practice characteristics shaped a practice’s response to
the intervention. Qualitative data collected during the
medical record review, concerning where data were
found in the record and with what kind of practicebased standardization, will be included in this analysis.
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resources (such as expert facilitators), may be effective but
lack replicability in everyday practice or sustainability.
SPARC could show that using existing resources to support
implementation can be effective and sustainable. In doing
so, it could affect design of future interventions intended to
guide primary care practice work process change.

Additional file
Trial status

Recruitment was conducted February to November
2014, with 30 practices currently enrolled in SPARC.
The first champion meeting for control practices is
scheduled to take place in March 2015, and we anticipate starting baseline data collection activities at that
time. The first champion meeting for intervention
practices will be held soon thereafter, with baseline data
collection for that group beginning immediately after.
Baseline data collection for control and intervention
groups will be completed by June 2015. Data cleaning
and analysis of preliminary baseline data will begin soon
after baseline collection is complete.

Discussion
As primary care practices around the country see a
steady increase in the number of patients with chronic
conditions, the importance of transforming work processes
and adopting population-based approaches to care is
heightened. However, many practices lack the internal flexibility or external support to integrate population-based care
concepts into their everyday care processes. SPARC will test
the effectiveness of a low-cost intervention designed to help
primary care practices implement a population-based approach to care by developing a diabetes registry, while paying attention to work process change. All participating
practices will have access to basic information on using
population health approaches in primary care settings, developing registries, and preparing for work process change.
Intervention practices will have additional assistance from
peer mentors who have already developed and sustained a
proactive diabetes registry in their practice.
The project period is 5 years, with 3 years for practice
participation and data collection. The length of the project will enable the SPARC research team to determine
the factors necessary for practices to successfully implement and sustain a diabetes registry. The SPARC research team also will be able to explore what other
aspects of a practice are affected after registry implementation. For example, it is expected that practices that
successfully implement a registry will see improvements
in overall outcomes for their patients and increase
standardization in medical record documentation.
SPARC is an innovative, low-cost intervention for
transformational practice change. Previous studies, designed around high-cost interventions that rely on outside

Additional file 1: SPARC Milestones. This document was shared with
the intervention practices and outlines eight critical steps in the meaningful
adoption of a diabetes registry.
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